Saem Research is building Australia's leading women's health diagnostics platform, based in New South Wales.
We identify, develop, and commercialise innovative technologies that improve the health of women, mothers, and babies. Our current portfolio includes EveryBaby, a portable point-of-care diagnostic for early preterm birth risk assessment based on cervical electrical impedance spectroscopy (EIS), and snapi, a maternal microbiome qPCR-based risk assessment platform.
EveryBaby is an investigational, minimal-invasive medical device that uses cervical electrical impedance to support preterm birth risk assessment. The device integrates dedicated hardware, embedded software, and clinical AI, and is being evaluated through multi-site clinical studies in Australia and additional jurisdictions.
Investigational · Not approved for sale View EveryBaby research →
snapi is an investigational microbiome-based program for identifying women at elevated risk of preterm birth in early pregnancy. A microbiome matrix has been established in a Korean cohort, and Saem Research is designing a clinical study in Australia to extend the dataset across additional ethnic populations.
Investigational · Not approved for sale View snapi research →Saem Research is a women's health innovation and commercialisation platform focused on identifying, developing, and translating promising technologies into accessible healthcare solutions.
Our work spans research, product development, clinical validation, regulatory strategy, and commercialisation. While our operations are centred in New South Wales, our ambition is global: to accelerate the adoption of breakthrough diagnostics and technologies that improve outcomes for women and families.
Clinical engagement is underway with leading maternity institutions, including Westmead Hospital and the University of Sydney Reproduction and Perinatal Centre.
Sunny Gong is the Founder and CEO of Saem Research, co-inventor of the EveryBaby technology, and an experienced cross-border MedTech operator.
She has spent her career bringing together researchers, clinicians, industry partners, and investors to advance healthcare innovations from concept to clinical impact. At Saem Research, she leads the company's mission to discover, develop, and commercialise technologies that improve the health of women, mothers, and babies.
If you build, distribute, fund, or invest at the intersection of maternal-infant health — let's talk.
For investors and funders evaluating Saem Research and its maternal-health R&D pipeline.
Request the deckFor clinical, diagnostics, and commercial partners exploring co-development and validation.
Discuss a partnership